Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charlotte Daker, MD
University of Auckland, New Zealand
Principal Investigator - Greg O'Grady, MD, PhD
University of Auckland, New Zealand
Principal Investigator - Henry Parkman, MD
Temple University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Recruiting
- Te Whatu Ora Waitemata
Auckland, Auckland, New Zealand
Charlotte Daker, MDRecruiting
- Temple University
Philadelphia, Pennsylvania, United States
Henry Parkman, MD, PhDNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Feb 2025
- Primary completion
- 26 Feb 2028
- Completion
- 26 Aug 2028
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 125
- Registry id
- NCT06854120
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.